
Factor XI Deficient Plasma (1 × 1 mL) — <1% Residual
Product DescriptionFor Research Use Only. Not for Use in Diagnostic Procedures. Lyophilized human citrated plasma immunodepleted for Factor XI (FXI). Residual FXI activity <1%. CE-IVD. 1 × 1 mL. Substrate for FXI one-stage APTT-based clotting assay. FXI deficiency (hemophilia C) causes variable bleeding — severe deficiency leads to surgery-related bleeding but not spontaneous bleeding. Particularly prevalent in Ashkenazi Jewish populations. Use with CEPHEN™ for FXI intrinsic pathway assay.
Product Characteristics
Product Components
|
Product ApplicationsFor measurement of Factor XI (FXI or Rosenthal Factor) activity in research applications. For any in vitro protocol or research study where a source of human FXI deficient plasma is required. Associated calibrator and controls are available: BIOPHEN Plasma Calibrator (Ref A222101-RUO), BIOPHEN Normal Control Plasma (Ref A223201-RUO) and BIOPHEN Abnormal Control Plasma (Ref A223301-RUO). |